PREVALENCE OF G-TO-T TRANSVERSIONS AMONG K-RAS ONCOGENE MUTATIONS IN HUMAN COLORECTAL TUMORS IN YUGOSLAVIA

被引:59
作者
UROSEVIC, N
KRTOLICA, K
SKAROMILIC, A
KNEZEVICUSAJ, S
DUJIC, A
机构
[1] MIL MED ACAD, INST MED RES, BELGRADE, YUGOSLAVIA
[2] MIL MED ACAD, INST PATHOL & FORENS MED, BELGRADE, YUGOSLAVIA
[3] INST NUCL SCI VINCA, RADIOBIOL & MOLEC GENET LAB, BELGRADE, YUGOSLAVIA
关键词
D O I
10.1002/ijc.2910540215
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Human colorectal carcinoma tissue sampled from 37 patients, routinely graded into Dukes' stages A, B and C and histologically examined for the level of differentiation, were analyzed for the presence of point mutations in the K-ras oncogene. Seventeen cases out of the 37 analyzed were found to have a mutation in either the 12th or the 13th codon of the K-ras gene, giving an overall frequency of mutation of 46%. The incidence of mutations in Dukes' stages A, B and C was 33, 46 and SB% respectively. Although the frequency of mutation appears to be similar to that reported for the USA population, the spectrum of point mutations in codons 12 and 13 of the K-ras gene in the Yugoslav population appears to differ significantly. G-to-T transversions make up 77% of all mutations present, with the distribution as follows: 18% at the first base and 59% at the second base of codons 12 and 13. G-to-A transitions at the second base is the only other mutation identified, occurring mainly in codon 13 in colorectal tumors of all 3 stages.
引用
收藏
页码:249 / 254
页数:6
相关论文
共 33 条
[11]   The classification of cancer of the rectum [J].
Dukes, CE .
JOURNAL OF PATHOLOGY AND BACTERIOLOGY, 1932, 35 (03) :323-332
[12]   CARCINOGENIC EPOXIDES OF BENZO[A]PYRENE AND CYCLOPENTA[CD]PYRENE INDUCE BASE SUBSTITUTIONS VIA SPECIFIC TRANSVERSIONS [J].
EISENSTADT, E ;
WARREN, AJ ;
PORTER, J ;
ATKINS, D ;
MILLER, JH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1982, 79 (06) :1945-1949
[13]   A GENETIC MODEL FOR COLORECTAL TUMORIGENESIS [J].
FEARON, ER ;
VOGELSTEIN, B .
CELL, 1990, 61 (05) :759-767
[14]   DETECTION OF HIGH-INCIDENCE OF K-RAS ONCOGENES DURING HUMAN-COLON TUMORIGENESIS [J].
FORRESTER, K ;
ALMOGUERA, C ;
HAN, KY ;
GRIZZLE, WE ;
PERUCHO, M .
NATURE, 1987, 327 (6120) :298-303
[15]   ASSOCIATION OF KI-RAS MUTATION WITH DIFFERENTIATION AND TUMOR-FORMATION PATHWAYS IN COLORECTAL-CARCINOMA [J].
LAURENTPUIG, P ;
OLSCHWANG, S ;
DELATTRE, O ;
VALIDIRE, P ;
MELOT, T ;
MOSSERI, V ;
SALMON, RJ ;
THOMAS, G .
INTERNATIONAL JOURNAL OF CANCER, 1991, 49 (02) :220-223
[16]   RAS GTPASE ACTIVATING PROTEIN - SIGNAL TRANSMITTER AND SIGNAL TERMINATOR [J].
MCCORMICK, F .
CELL, 1989, 56 (01) :5-8
[17]   NUCLEAR ROUNDNESS FACTOR MEASUREMENT FOR ASSESSMENT OF PROGNOSIS OF PATIENTS WITH PROSTATIC-CARCINOMA .2. STANDARDIZATION OF METHODOLOGY FOR HISTOLOGIC SECTIONS [J].
MOHLER, JL ;
PARTIN, AW ;
EPSTEIN, JI ;
LOHR, WD ;
COFFEY, DS .
JOURNAL OF UROLOGY, 1988, 139 (05) :1085-1090
[18]  
NEWCOMB EW, 1988, CANCER RES, V48, P5514
[19]   DIFFERENTIAL ACTIVATION OF RAS GENES BY POINT MUTATION IN HUMAN COLON CANCER WITH METASTASES TO EITHER LUNG OR LIVER [J].
OUDEJANS, JJ ;
SLEBOS, RJC ;
ZOETMULDER, FAN ;
MOOI, WJ ;
RODENHUIS, S .
INTERNATIONAL JOURNAL OF CANCER, 1991, 49 (06) :875-879
[20]   CARCINOGEN-SPECIFIC MUTATION AND AMPLIFICATION OF HA-RAS DURING MOUSE SKIN CARCINOGENESIS [J].
QUINTANILLA, M ;
BROWN, K ;
RAMSDEN, M ;
BALMAIN, A .
NATURE, 1986, 322 (6074) :78-80